Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary structure of CD52

A Treumann1, M R Lifely, P Schneider

  • 1Department of Biochemistry, University of Dundee, Scotland, United Kingdom.

The Journal of Biological Chemistry
|March 17, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A randomised controlled clinical trial to assess the benefits of a telecare tool delivered prior to the initial hearing assessment.

International journal of audiology·2022
Same author

Increased Functional Connectivity After Listening to Favored Music in Adults With Alzheimer Dementia.

The journal of prevention of Alzheimer's disease·2018
Same author

[The established and reintroduced markers of kidney functions].

Klinicheskaia laboratornaia diagnostika·2014
Same author

Growth factor receptor/steroid receptor cross talk in trastuzumab-treated breast cancer.

Oncogene·2014
Same author

Platelets increase survival of adenocarcinoma cells challenged with anticancer drugs: mechanisms and implications for chemoresistance.

British journal of pharmacology·2012
Same author

Functional connectivity targeting for deep brain stimulation in essential tremor.

AJNR. American journal of neuroradiology·2011

This study details the purification and characterization of two CD52 antigen species (CD52-I and CD52-II) from human spleens. The findings reveal distinct phosphatidylinositol (PI) anchor structures, impacting antibody binding and offering insights into glycosylphosphatidylinositol (GPI) anchor variations.

Area of Science:

  • Biochemistry
  • Immunology
  • Glycobiology

Background:

  • The CD52 antigen is a target for therapeutic antibodies, but its precise molecular structure, particularly its glycosylphosphatidylinositol (GPI) anchor, remains incompletely understood.
  • Understanding the structural heterogeneity of CD52 is crucial for optimizing antibody-based therapies and interpreting their mechanisms of action.

Purpose of the Study:

  • To purify and structurally characterize CD52 antigen from human spleens.
  • To elucidate the distinct molecular differences between CD52-I and CD52-II species, focusing on their GPI anchor composition.
  • To investigate the role of GPI anchor structure in the binding of the Campath-1H monoclonal antibody.

Main Methods:

  • Extraction of CD52 antigen from human spleens using organic solvents.

Related Experiment Videos

  • Purification via immunoaffinity and reverse-phase chromatography, resolving CD52-I and CD52-II.
  • Characterization of N-linked oligosaccharides using methylation linkage analysis and reagent array analysis.
  • Determination of GPI anchor glycan phosphoryl substituents via partial acid hydrolysis.
  • Analysis of phosphatidylinositol (PI) moieties using electrospray ionization mass spectrometry and tandem mass spectrometry.

    • Main Results:

    • Two CD52 species, CD52-I and CD52-II, were isolated, possessing similar N-linked oligosaccharides but differing PI moieties in their GPI anchors.
    • CD52-I contained exclusively distearoyl-PI, while CD52-II predominantly featured a palmitoylated stearoyl-arachidonoyl-PI with palmitoylation at the 2-position of the myo-inositol ring.
    • The N-glycosylation site was occupied by large, sialylated, polylactosamine-containing, core-fucosylated tetraantennary oligosaccharides.
    • Alkali-labile hydroxyester-linked fatty acids in the GPI anchor appear necessary for binding by the Campath-1H antibody.

    Conclusions:

    • The structural heterogeneity in the PI moiety of GPI anchors for CD52 is significant and unusual.
    • These structural variations in CD52 may influence its biological function and interaction with antibodies.
    • The findings provide a deeper understanding of CD52 antigen structure, relevant for the development and application of CD52-targeting therapies.